Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 21, 2017
Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)
Takuya Awata, Akira Shimada, Taro Maruyama, et al.
Annals of the New York Academy of Sciences
|
February 9, 2005
GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9
Arata Itoh, Akira Shimada, Keiichi Kodama, et al.
Journal of Diabetes Investigation
|
December 27, 2021
HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019
Shinnosuke Yanagisawa, Yoichi Oikawa, Sotaro Takagi, et al.
Diabetes Research and Clinical Practice
|
June 1, 2026
The first epidemiological study of presymptomatic type 1 diabetes among first-degree relatives in Japan: PREP-T1D study
Daisuke Chujo, Tomoyuki Kawamura, Toru Kikuchi, et al.
Diabetology International
|
January 24, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International
|
January 29, 2025
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International
|
August 5, 2024
Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Journal of Diabetes Investigation
|
November 12, 2024
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Journal of Diabetes Investigation
|
January 7, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International
|
January 4, 2019
Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in Japan
Yoichi Oikawa, Akira Shimada, Takuya Awata, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 21, 2017
Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)
Takuya Awata, Akira Shimada, Taro Maruyama, et al.
Annals of the New York Academy of Sciences
|
February 9, 2005
GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9
Arata Itoh, Akira Shimada, Keiichi Kodama, et al.
Journal of Diabetes Investigation
|
December 27, 2021
HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019
Shinnosuke Yanagisawa, Yoichi Oikawa, Sotaro Takagi, et al.
Diabetes Research and Clinical Practice
|
June 1, 2026
The first epidemiological study of presymptomatic type 1 diabetes among first-degree relatives in Japan: PREP-T1D study
Daisuke Chujo, Tomoyuki Kawamura, Toru Kikuchi, et al.
Diabetology International
|
January 24, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International
|
January 29, 2025
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English Version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International
|
August 5, 2024
Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Journal of Diabetes Investigation
|
November 12, 2024
Practice guideline: Statement regarding treatment for suspected slowly progressive type 1 diabetes (SPIDDM; probable) cases (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Journal of Diabetes Investigation
|
January 7, 2024
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version)
Akira Shimada, Eiji Kawasaki, Norio Abiru, et al.
Diabetology International
|
January 4, 2019
Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in Japan
Yoichi Oikawa, Akira Shimada, Takuya Awata, et al.
Page
of 11